Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1053/j.ajkd.2013.11.015 http://scihub22266oqcxt.onion/10.1053/j.ajkd.2013.11.015 C4069228!4069228!24387795     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Kidney+Dis 2014 ; 64 (1): 95-103 Nephropedia Template TP {{tp|p=24387795|t=2014. Comparative Effectiveness of Calcium Acetate and Sevelamer on Clinical Outcomes in Elderly Hemodialysis Patients Enrolled in Medicare Part D |pdf=|usr=}}{{24387795}} gab.com Text Comparative Effectiveness of Calcium Acetate and Sevelamer on Clinical Outcomes in Elderly Hemodialysis Patients Enrolled in Medicare Part D JO: Am J Kidney Dis http://www.kidney.de/pget.php?&tw=1&pmid=24387795 #FOAvip Background: Phosphate binders are an important therapeutic option for managing hyperphosphatemia in hemodialysis patients. Whether sevelamer confers a survival advantage over calcium acetate is unclear. Study Design: Observational cohort study using US Renal Data System (USRDS) data linked to Medicare Part D prescription drug data. Setting & Participants: Medicare-enrolled, elderly, incident hemodialysis patients initiating calcium acetate or sevelamer between July 1, 2006, and March 31, 2011. Predictor: Prescription for sevelamer (hydrochloride or carbonate) or calcium acetate. Outcomes & measurements: All-cause and cardiovascular-related mortality, hospital admissions and hospital days assessed from Medicare Parts A, B, and D claims and other USRDS data. Results: The sevelamer and calcium acetate groups included 16,916 and 18,335 patients, respectively. After multivariable adjustment, all-cause (21.9 versus 21.8 deaths per 100 patient-years; adjusted HR, 0.97; 95% CI, 0.94-1.03) and cardiovascular (8.7 versus 8.6 deaths per 100 patient-years; HR, 0.99; 95% CI, 0.93-1.04) mortality did not differ significantly between the sevelamer group and calcium acetate group (referent). Mortality results in propensity-score matched cohorts showed a significantly lower risk of death in sevelamer than in calcium acetate patients (HR, 0.94; 95% CI, 0.91-0.98). Mortality results from additional analyses including only patients with low-income subsidy status were consistent with results from analyses including patients with and without low-income subsidy status. There were no significant differences between the sevelamer and calcium acetate groups for all-cause and cardiovascular-related first hospitalization, multiple hospitalizations, and hospital days. Limitations: Results may not be applicable to younger patients; information about laboratory data and over-the-counter calcium-containing binders was lacking. Conclusions: Relative to treatment with calcium acetate, treatment with sevelamer was associated with similar or slightly lower risk of death and similar risk of hospitalization in elderly incident hemodialysis patients. Twit Text FOAVip Comparative Effectiveness of Calcium Acetate and Sevelamer on Clinical Outcomes in Elderly Hemodialysis Patients Enrolled in Medicare Part D ????Am J Kidney Dis http://www.kidney.de/pget.php?&tw=1&pmid=24387795 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24387795 #FOAvip English Wikipedia <ref>{{Cite pmid|24387795}}</ref> Comparative Effectiveness of Calcium Acetate and Sevelamer on Clinical Outcomes in Elderly Hemodialysis Patients Enrolled in Medicare Part D #MMPMID24387795 Yusuf AA; Weinhandl ED; St. Peter WL Am J Kidney Dis 2014[Jul]; 64 (1): 95-103 PMID24387795show ga Background: Phosphate binders are an important therapeutic option for managing hyperphosphatemia in hemodialysis patients. Whether sevelamer confers a survival advantage over calcium acetate is unclear. Study Design: Observational cohort study using US Renal Data System (USRDS) data linked to Medicare Part D prescription drug data. Setting & Participants: Medicare-enrolled, elderly, incident hemodialysis patients initiating calcium acetate or sevelamer between July 1, 2006, and March 31, 2011. Predictor: Prescription for sevelamer (hydrochloride or carbonate) or calcium acetate. Outcomes & measurements: All-cause and cardiovascular-related mortality, hospital admissions and hospital days assessed from Medicare Parts A, B, and D claims and other USRDS data. Results: The sevelamer and calcium acetate groups included 16,916 and 18,335 patients, respectively. After multivariable adjustment, all-cause (21.9 versus 21.8 deaths per 100 patient-years; adjusted HR, 0.97; 95% CI, 0.94-1.03) and cardiovascular (8.7 versus 8.6 deaths per 100 patient-years; HR, 0.99; 95% CI, 0.93-1.04) mortality did not differ significantly between the sevelamer group and calcium acetate group (referent). Mortality results in propensity-score matched cohorts showed a significantly lower risk of death in sevelamer than in calcium acetate patients (HR, 0.94; 95% CI, 0.91-0.98). Mortality results from additional analyses including only patients with low-income subsidy status were consistent with results from analyses including patients with and without low-income subsidy status. There were no significant differences between the sevelamer and calcium acetate groups for all-cause and cardiovascular-related first hospitalization, multiple hospitalizations, and hospital days. Limitations: Results may not be applicable to younger patients; information about laboratory data and over-the-counter calcium-containing binders was lacking. Conclusions: Relative to treatment with calcium acetate, treatment with sevelamer was associated with similar or slightly lower risk of death and similar risk of hospitalization in elderly incident hemodialysis patients. äComparative Effectiveness of Calcium Acetate and Sevelamer on Clinical(epmc).pdf DeepDyve Pubget Overpricing